N-cadherin expression in head and neck cancer by Nguyen, Phuong Thao et al.
Summary. The loss of E-cadherin and the gain of N-
cadherin expression are known as “cadherin switching”.
Cadherin switching is a major hallmark of epithelial-
mesenchymal transition (EMT). EMT is a crucial
process in cancer progression, providing cancer cells
with the ability to escape from the primary focus, to
invade stromal tissues and to migrate to distant regions.
Although down-regulation of E-cadherin is well known
in various cancers, there are a few studies on N-cadherin
expression in cancer. Here, therefore, we investigated
whether N-cadherin expression was associated with the
progression of head and neck squamous cell carcinoma
(HNSCC). First, we examined the expression of N-
cadherin by immunohistochemistry and its correlation
with clinico-pathological findings. High expression of
N-cadherin was observed in 52 of 80 HNSCC cases and
was significantly correlated with malignant behaviors.
Next, we examined the correlation between N-cadherin
and E-cadherin. Cadherin switching (high expression of
N-cadherin and low expression of E-cadherin) was
found in 30 of 80 HNSCC cases and was well correlated
with histological differentiation, pattern of invasion and
lymph node metastasis in HNSCC cases. Moreover, we
examined the expression of N-cadherin and E-cadherin
by RT-PCR in 16 HNSCC cell lines to confirm the
immunohistochemical findings. N-cadherin expression
was observed in 7 of 16 HNSCC cells, and cadherin
switching was observed in 2 HNSCC cells. Interestingly,
HNSCC cells with cadherin switching have EMT
features. In conclusion, we suggest that i) N-cadherin
may play an important role in malignant behaviors of
HNSCC, and ii) cadherin switching might be considered
as a discrete critical event in EMT and metastatic
potential of HNSCC. 
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Introduction
Head and neck squamous cell carcinoma (HNSCC)
is one of the most common types of human cancer, with
an annual incidence of more than 500,000 cases
worldwide (Mao et al., 2004). The extent of lymph node
metastasis is a major determinant in the prognosis of
HNSCC. Like most epithelial cancers, HNSCC develops
through the accumulation of multiple genetic and
epigenetic alterations in a multistep process (Fidler,
1990). One of the most characteristic clinical features of
HNSCC is its capacity to invade the adjacent tissues and
metastasize. Therefore, attempts to identify the genes
involved in the invasion and/or metastasis are pivotal for
the early prediction of HNSCC behavior. During tumor
progression, cancer cells undergo dramatic changes in
the expression profile of adhesion molecules, resulting in
detachment from original tissue and acquisition of a
highly motile and invasive phenotype. A hallmark of this
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change is referred to as EMT (Gupta and Massagué,
2006; Thiery, 2003). A key to EMT is the reduction of
cell-cell adhesion by transcriptional repression of
cadherin (Mariotti et al., 2007; Maeda et al., 2004). 
Cadherins are a family of transmembrane proteins
that mediate Ca2+-dependent cell-cell adhesion. Of the
members of the cadherin family, E-cadherin is
distributed widely and is the most important intercellular
adhesion molecule in epithelial cells. Although E-
cadherin is well documented as an invasive suppressor
for cancer cells, the role of anomalously expressed N-
cadherin in epithelial cells has only recently been
identified more clearly (Derycke and Bracke, 2004).
Unlike E-cadherin, N-cadherin is normally expressed in
neuroectodermal and mesodermal-derived tissue and is
involved in a lot of processes, such as cell-cell adhesion,
differentiation, embryogenesis, migration, invasion and
signal transduction (Derycke and Bracke, 2004). N-
cadherin is also expressed in human endothelial cells,
but its function in angiogenesis is not fully elucidated
(Diamond et al., 2008). Aberrant expression of N-
cadherin is considered to be associated with increased
tumor progression in certain cancers (Derycke and
Bracke, 2004). In particular, increased expression of N-
cadherin and concomitant down-regulation of E-
cadherin are suggested to be a feature of EMT in cancer
(Yilmaz and Christofori, 2009). However, the
mechanism by which increased expression of N-cadherin
promotes malignancy is not completely understood. To
find out the involvement of N-cadherin in the
progression of HNSCC, we examined the expression of
N-cadherin and compared it with E-cadherin expression
and clinico-pathological parameters. 
Materials and methods
Clinical data and tissue samples
Eighty paraffin-embedded HNSCC cases were
retrieved from the pathological files of Cancer Hospital
in Ho Chi Minh city, Vietnam in 2008, after approval by
the Ethical Committee of our institutions. Clinical details
and lymph node metastasis were gathered from surgical
records of the patients. For the present analysis, only
specimens without radio-chemotherapy were selected to
avoid possible influences of the treatment modalities on
data. For evaluation of invasion pattern of HNSCC, we
used the grading of mode of invasion (Grade I has a well
defined borderline, Grade II has a less-marked
borderline, Grade III has groups of cells and no distinct
borderline, and Grade IV has diffuse growth) as first
described by Jacobsson et al. (1973). The histological
grade was classified according to the WHO diagnostic
criteria for histological typing of cancer and pre-cancer
of the oral mucosa (Pindborg et al., 1997).
Fresh frozen tissues of HNSCC were obtained from
55 patients who underwent surgery at Cancer Hospital in
Ho Chi Minh city, Vietnam. These tissue specimens
were immediately frozen and stored at -80°C before
using. Informed consent was obtained from all patients
for this study. 
Immunohistochemistry
Unstained 4.5 µ m sections were cut from each
paraffin block then de-paraffinized and rehydrated by
routine techniques. Endogenous peroxidase activity was
blocked with 0.3% H2O2 in methanol for 30 minutesbefore doing antigen retrieval by microwave treatment in
Tris-EDTA buffer pH 9.0 and in citrate phosphate buffer
for N-cadherin and E-cadherin, respectively, for 20
minutes. The sections were then incubated with protein
block serum-free solution in 10 minutes. N-cadherin and
E-cadherin monoclonal antibodies (BD Transduction
Laboratories) were diluted with PBS (1:30 and 1:150,
respectively) and incubated overnight at 4°C. After
washing three times by PBS, the sections were incubated
with appropriate peroxidase-labeled secondary
antibodies for 1 hour at room temperature. The sections
were then labeled by diaminobenzidine and were
counterstained with Mayer’s haematoxyline, dehydrated
and mounted. Evaluation of immunostaining was based
on proportion of stained cancer cells and location of
staining. N-cadherin and E-cadherin expression was
scored on a semi-quantitative scale by evaluating the
percentage of stained cells within representative areas of
each tumor. For superficial carcinomas, stained sections
were observed throughout the lesion. For advanced large
tumors, at least ten fields including superficial, central
and deep invasive areas were observed and the number
of stained cells and staining intensity were evaluated. In
each field, we counted more than 300 cells using an
eyepiece graticule to prevent recounting. For N-
cadherin, the samples were then divided into two groups;
low (less than 20% of the cancer cells were stained) and
high (over 20% of the cancer cells were stained). E-
cadherin was defined as preserved (over 80% of cancer
cells exhibited a staining pattern similar to that in normal
epithelial cells) and reduced (less than 80% of the cancer
cells exhibited a staining pattern similar to that in normal
epithelial cells).
Statistical analysis
Correlations between the expression pattern of N-
cadherin and E-cadherin and the clinico-pathological
features of HNSCC were examined using Chi-square
test. Statistical analysis was performed using SPSS 13.0
and statistical significance was defined as P<0.05.
Reverse transcription-polymerase chain reaction (RT-
PCR)
Total RNA was isolated and purified from the fresh
frozen HNSCC tissues and cells by using RNeasy Mini
Kit (Qiagen, Hilden, Germany). Preparations were
quantified and their purity was determined by standard
spectrophometric methods. cDNA was synthesized from
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1µg total RNA according to the ReverTra Dash (Toyobo
Biochemicals, Tokyo, Japan). Primer sequences included
the following; 
Aliquots of total cDNA were amplified with 1.25 U
of rTaq-DNA polymerase (Qiagen), and amplifications
were performed in a PC701 thermal cycler (Astec,
Fukuoka, Japan) for 25-35 cycles after an initial 30 sec
denaturation at 94°C, annealed for 30 sec at 60°C, and
extended for 1 min at 72°C in all primers. The
amplification reaction products were resolved on 1.2 %
agarose/TAE gels, electrophoresed at 135 mV, and
visualized by ethidium-bromide staining.
Cell lines and cell culture
A total of 16 HNSCC cell lines were used for the
study. HSC2, HSC3, HSC4, Ca9-22, Ho-1-N-1 and Ho-
1-U-1 cells were provided by Japanese Collection of
Research Bioresources Cell Bank. HOC119, HOC313,
HOC621, HOC719-PE, HOC719-NE, TSU, OM-1 and
ZA cells have been described previously (Yokoyama et
al., 2001). KOSCC11 and KOSCC25B were obtained
from Dr. S.P. Hong (Seoul National University). All
these cells were maintained in RPMI-1640 or DMEM
(Nissui Pharmaceutical Co., Tokyo, Japan)
supplemented with 10% heat-inactivated FBS
(Invitrogen) and 100 U/ml penicillin-streptomycin
(Gibco) under conditions of 5% CO2 in air at 37°C. 
Results
N-cadherin expression and its correlation with clinico-
pathological findings 
To discover the role of N-cadherin in the progression
of HNSCC, we examined the immunohistochemical
expression of N-cadherin and its correlation with
clinico-pathological findings in 80 HNSCC cases. The
relationship between N-cadherin and clinico-
pathological findings including pattern of invasion,
histological differentiation, stage grouping and lymph
node metastasis in HNSCC is summarized in Table 1.
For pattern of invasion, we classified as low grade
(grade I & II) and high grade (grade III & IV), according
to the classification described by Jacobsson et al. (1973).
High expression of N-cadherin was observed in 52
(65%) of 80 HNSCC cases (Fig. 1A and Table 1). N-
cadherin expression was found in the membrane and
cytoplasm of cancer cells (Fig. 1A). On the other hand,
N-cadherin expression was not observed in normal
epithelia. Interestingly, N-cadherin expression was
significantly correlated with pattern of invasion (Fig.
1B), histological differentiation (Fig. 1C) and stage
grouping (Fig. 1D).
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human N-cadherin 5’-GACAATGCCCCTCAAGTGTT-3’ (forward) 
5’-CCATTAAGCCGAGTGATGGT-3’ (reverse) 
human E-cadherin 5’-TGCCCAGAAAATGAAAAAGG-3’ (forward) 
5’-GGATGACAGCGTGAGAGA-3’ (reverse) 
human vimentin 5’-CCCTCACCTGTGAAGTGGAT-3’ (forward) 
5’-TCCAGCAGCTTCCTGTAGGT-3’ (reverse)
human ß-catenin 5’-CCCACTAATGTCCAGCGTTT-3’ (forward) 
5’-AACGCATGATAGCGTGTCTG-3’ (reverse) 
human fibronectin 5’-TCCACAAGCGTCATGAAGAG-3’ (forward) 
5’-ATACCACACCAGGCTTCAGG-3’ (reverse)
human vitronectin 5’-TCAACGTGGACAAGAAGTGC-3’ (forward) 
5’-TGAGGTCTCCCTGGATGAAG-3’ (reverse)
human alpha-smooth
muscle actin 5’-CCGGGAGAAAATGACTCAAA-3’ (forward) 
5’-GAAGGAATAGCCACGCTCAG-3’ (reverse); 
human GAPDH 5’-ACAGTCAGCCGCATCTTCTT-3 (forward) 
5’-TTGATTTTGGAGGGATCTCG-3’ (reverse)
Table 1. Relationship of N-cadherin with E-cadherin expression and clinico-pathological findings.
N-cadherin expression* E-cadherin expression**
HNSCC Low HIgh P Preserved Reduced P
Total 28 52 38 42
Pattern of invasion 0.002 0.014
Low grade 20 19 24 15
High grade 8 33 14 27
Histological differentiation 0.002 0.219
Well & Moderate 26 32 30 28
Poorly 2 20 8 14
Stage 0.039 0.541
I & II 14 14 12 16
III & IV 14 38 26 26
Lymph node metastasis 0.45 0.16
Negative 16 22 24 20
Positive 12 30 14 22
*For N-cadherin, the samples were then divided into two groups; low (less than 20% of the cancer cells were stained) and positive (over 20% of the
cancer cells were stained). **E-cadherin was defined as preserved (over 80% of cancer cells exhibited a staining pattern similar to that in normal
pithelial cells) and reduced (less than 80% of the cancer cells exhibited a staining pattern similar to that in normal epithelial cells).
N-cadherin expression and its correlation with E-
cadherin expression
Next, we examined E-cadherin expression in
HNSCC cases to compare it with N-cadherin expression.
E-cadherin expression was preserved in the non-
cancerous epithelial cells but reduced in the cancer cells
(Fig. 2A). Reduced expression of E-cadherin was
significantly correlated with pattern of invasion (Table
1). Reduced expression of E-cadherin was shown in
57.7% of HNSCC cases with high expression of N-
cadherin and high expression of N-cadherin was shown
in 71.4% of HNSCC cases with reduced expression of E-
cadherin (Fig. 2B).
The loss of E-cadherin and the gain of N-cadherin
expression are known as “cadherin switching”.
Therefore, to find out the correlation between cadherin
switching and clinico-pathological findings, HNSCC
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Fig. 1. Expression of N-cadherin and its correlation with clinico-
pathological findings in HNSCC. A. Immunohistochemical staining of N-
cadherin in HNSCC cases. The upper panel shows lower magnification
(x 40) and the lower panel shows higher magnification (x 200). B.
Correlation between N-cadherin expression and pattern of invasion (low
grade and high grade). Graph shows the percentage of cases with high
or low expression of N-cadherin in each group (high or low grade of
invasion pattern). C. Correlation between N-cadherin expression and
histological differentiation (well, moderate and poor). Graph shows the
percentage of cases with high or low expression of N-cadherin in each
group (well & moderate or poor). D. Correlation between N-cadherin
expression and stage grouping (I, II III and IV). Graph shows the
percentage of cases with high or low expression of N-cadherin in each
group (I & II or III & IV of stage grouping).
Fig. 2. Cadherin switching and its correlation with clinico-pathological findings in HNSCC. A. Immunohistochemical staining of N-cadherin (left panel)
and E-cadherin (right panel) in HNSCC cases. The upper panel shows lower magnification (x40) and the lower panel shows higher magnification
(x100). B. Correlation between N-cadherin expression and E-cadherin expression (preserved and reduced). In the upper panel, the graph shows the
percentage of cases with preserved or reduced expression of E-cadherin in each group (low or high expression of N-cadherin). In the lower panel, the
graph shows the percentage of cases with high or low expression of N-cadherin in each group (preserved or reduced expression of E-cadherin). C.
Correlation between cadherin switching and pattern of invasion (low grade and high grade). HNSCC cases were classified into 4 groups, depending on
the status of N-cadherin and E-cadherin expression; i) high expression of N-cadherin and reduced expression of E-cadherin, ii) high expression of N-
cadherin and preserved expression of E-cadherin, iii) low expression of N-cadherin and preserved expression of E-cadherin, and iv) low expression of
N-cadherin and reduced expression of E-cadherin. The graph shows the percentage of cases with low or high grade of invasion pattern in each of the 4
groups. D. Correlation between cadherin switching and histological differentiation (well, moderate and poor). Graph shows the percentage of cases with
well and moderate or poor differentiation in each of the 4 groups. E. Correlation between cadherin switching and lymph node metastasis (negative and
positive). The graph shows the percentage of cases with negative or positive of lymph node metastasis in each of the 4 groups.
cases were classified into 4 groups, depending on the
status of N-cadherin and E-cadherin expression; i) high
expression of N-cadherin and reduced expression of E-
cadherin, ii) high expression of N-cadherin and
preserved expression of E-cadherin, iii) low expression
of N-cadherin and preserved expression of E-cadherin,
and iv) low expression of N-cadherin and reduced
expression of E-cadherin, as shown in Table 2. HNSCC
cases with high expression of N-cadherin and reduced
expression of E-cadherin were defined as a Cadherin
switching group. HNSCC cases with cadherin switching
significantly showed malignant behaviors, including
high grade of invasion pattern (Fig. 2C) and poor
differentiation (Fig. 2D). HNSCC cases with cadherin
switching also showed high frequency of lymph node
metastasis, but there was no significant difference (Fig.
2E). In addition, HNSCC cases with high expression of
N-cadherin and preserved expression of E-cadherin also
showed a high grade of invasion pattern and poor
differentiation. 
We also examined the mRNA expression of N-
cadherin and E-cadherin in 55 fresh frozen HNSCC
tissues by RT-PCR and densitometric analysis of N-
cadherin and E-cadherin expression (Fig. 3A). The ratio
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Fig. 3. Cadherin switching in
HNSCC tissues. A. N-
cadherin and E-cadherin
mRNA expression in HNSCC
tissues. N-cadherin and E-
cadherin mRNA expression
was examined by RT-PCR in
55 HNSCC tissues. GAPDH
expression was used as a
positive control. Densitometric
analysis of N-cadherin and E-
cadherin expression was
performed. N-
cadherin/GAPDH ratio and E-
cadherin/GAPDH ratio are
shown. The status of lymph
node (LN) metastasis is
shown as posive (+) and
negative (-) and the results of
immunohistochemical (IHC)
analysis are shown as L (low),
H (high), R (reduced), P
(preserved) and ND (not
determined). B. Correlation
between the status of E-
cadherin and N-cadherin and
LN metastasis. HNSCC cases
were classified into 3 groups,
depending on the status of N-
cadherin and E-cadherin
expression; i) N>E; N-




is over 0.5-fold and less than
2-fold higher than E-
cadherin/GAPDH ratio, iii)
N<E; N-cadhein/GAPDH ratio
is less than 0.5-fold higher
than E-cadherin/GAPDH ratio.
The graph shows percentage
of cases with negative or
positive lymph node
metastasis in each of the 3
groups.
of N-cadherin/GAPDH and E-cadherin/GAPDH are
shown in Fig. 3A. Then, HNSCC cases were classified
into 3 groups (N>E, N=E and N<E), depending on the
status of N-cadherin and E-cadherin expression. Among
55 HNSCC tissues, 22 (40%) cases showed higher
expression of N-cadherin than E-cadherin (N>E).
Interestingly, HNSCC tissues with cadherin switching
(N>E group) significantly showed lymph node
metastasis (Fig. 3B). Among 55 cases, 32 cases were
available for immunohistochemical analysis to examine
the expression of N-cadherin and E-cadherin. We
compared the relationship between the results of RT-
PCR and immunohistochemistry, but we could not find a
possible relationship. This discrepancy may be
accounted for by translational regulation of N-cadherin
and E-cadherin expression.
Correlation between cadherin switching and EMT
Cadherin switching is a major hallmark of EMT. To
discover the correlation between cadherin switching and
EMT, we examined the expression of N-cadherin, E-
cadherin, ß-catenin and mesenchymal markers including
vimentin, α-SMA, fibronectin and vitronectin in 16
HNSCC cell lines. Among these cell lines, HOC313,
HOC719-NE, TSU and KOSCC25B cells showed loss of
E-cadherin expression and prominent expression of
vimentin (Fig. 4). HOC719-PE (positive E-cadherin) and
HOC719-NE (negative E-cadherin) cells were isolated
from HOC719 cells, which express E-cadherin
heterogeneously (Yokoyama et al., 2001). Moreover, it
has been shown previously that HOC719-NE, TSU and
HOC313 cells showed spindle morphology without E-
cadherin expression, high invasive activity and elevated
expression of Snail (Yokoyama et al., 2001, 2003; Taki
et al., 2003). KOSCC25B cells also showed spindle
morphology without E-cadherin expression (Hong et al.,
2009). Therefore, HOC313, HOC719-NE, TSU and
KOSCC25B are considered as EMT induced cells. In
these EMT induced cells, loss of E-cadherin expression
and expression of vimentin, α-SMA, fibronectin and
vitronectin were observed. Expression of vitronectin,
vimentin and E-cadherin was well correlated with EMT
induction. All HNSCC cells showed ß-catenin mRNA
expression. In 7 of 16 HNSCC cell lines (Ca9-22, Ho-1-
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Fig. 4. Correlation between cadherin switching
and EMT in HSNCC cell lines. N-cadherin, E-
cadherin, ß-catenin, vimentin, α-SMA,
fibronectin and vitronectin mRNA expression
were examined by RT-PCR in HNSCC cell
l ines. GAPDH expression was used as a
positive control. The arrow indicates specific
expression of vitronectin and the asterisk shows
non-specific bands. The EMT feature is also
shown.
Table 2. Correlation between cadherin switching and clinico-
pathological findings in HNSCC cases.
Total Other group Cadherin P
switching group
Total 80 50 30
Pattern of invasion 0.0004
Low grade 39 32 7
High grade 41 18 23
Histological differentiation 0.014
Well & Moderate 58 41 17
Poorly 22 9 13
Stage 0.467
I & II 28 19 9
III & IV 52 31 21
Lymph node metastasis 0.036
Negative 44 31 13
Positive 36 19 17
Cadherin switching group shows high expression of N-cadherin and
reduced expression of E-cadherin. The other 3 groups are i) high
expression of N-cadherin and preserved expression of E-cadherin, ii)
low expression of N-cadherin and preserved expression of E-cadherin,
and iii) low expression of N-cadherin and reduced expression of E-
cadherin.
N-1, HOC119, HOC313, HOC719-NE, ZA and
KOSCC11), N-cadherin expression was observed (Fig.
4). Among 4 HNSCC cell lines with EMT features,
HOC313 and HOC719-NE cells showed N-cadherin
expression (Fig. 4).
Discussion
It is known that cellular changes resulting in a more
mesenchymal-like state driven by EMT in cancer are
thought to play a major role in tumor progression. The
loss of E-cadherin and the gain of N-cadherin expression
are known as “cadherin switching” (Yilmaz and
Christofori, 2009). Cadherin switching is thought to
reflect an EMT, whereby tumor cells are released from
E-cadherin-dependent cell-cell interactions and acquire a
motile phenotype through the induction of N-cadherin.
In fact, here we found that cadherin switching was
observed in HOC313 and HOC719-NE cell lines with
EMT features such as spindle morphology, loss of E-
cadherin expression, high invasive ability and elevated
expression of Snail (Yokoyama et al., 2001, 2003; Taki
et al., 2003) (Fig. 4). Interestingly, the gain of N-
cadherin was concomitant to the loss of E-cadherin
expression in HNSCC cases (Fig. 2B). Thus, cadherin
switching was well correlated with EMT. Importantly,
we found that HNSCC cases with cadherin switching
showed malignant behaviors, including high grade of
invasion, poor differentiation and lymph node metastasis
(Fig. 2C-E and Table 2). We also found that cadherin
switching was found in spindle cell carcinoma
(unpublished data). As spindle cell carcinoma expresses
both epithelial and mesenchymal markers by
immunohistochemical analysis (Kudo et al., 2006; Zidar
et al., 2008), EMT may be involved in the pathogenesis
of spindle cell carcinoma (Zidar et al., 2008; Kojc et al.,
2009). It is worth examining the role of cadherin
switching for EMT induction in spindle cell carcinoma.
Interestingly, it has been shown that cadherin switching
is necessary for increased motility but is not required for
the morphological changes that accompany EMT
(Maeda et al., 2005). In addition to N-cadherin and E-
cadherin, other types of cadherins, including P-cadherin
and VE-cadherin are involved in EMT induction of
cancer. P-cadherin was shown as one major component
in reconfiguring mesenchymal cells with epithelial
features by triggering GSK-3ß-mediated inactivation and
cytoplasmatic translocation of Snail in oral squamous
cell carcinoma (Bauer et al., 2009). VE-cadherin was
induced during EMT in mammary tumor cells and was
aberrantly expressed in invasive human breast
carcinomas (Labelle et al., 2008). However, the
mechanism of EMT induction in cancer is still unknown
(Kalluri and Weinberg, 2009; Zeisberg and Neilson
2009). To understand EMT induction in cancer, other
EMT markers, including several types of cadherin,
should be examined.
It is well known that loss of E-cadherin expression is
frequently found during tumor progression in most
epithelial cancers (Cavallaro and Christofori, 2004). We
also previously demonstrated that methylation of E-
cadherin is involved in invasion and metastasis in
HNSCC (Kudo et a., 2004). On the other hand, aberrant
de novo expression of N-cadherin has been noted in
breast, prostate, and bladder cancers, where it parallels a
down-regulation of E-cadherin and a decrease in tumor
differentiation (Giroldi et al., 1999; Han et al., 1999;
Tomita et al., 2000). Up to now, there are few studies on
N-cadherin expression in HNSCC (Pyo et al., 2007;
Diamond et al., 2008; Li et al., 2009), and the clinical
benefit of N-cadherin expression is not clarified.
Therefore, here we investigated whether N-cadherin
expression was associated with the progression of
HNSCC. As previously shown in various cancers
(Mariotti et al., 2007), N-cadherin expression was found
in membrane and cytoplasm of HNSCC cells. In 65% of
HNSCC cases, high expression of N-cadherin was
observed by immunohistochemistry (Fig. 1B and Table
1). Moreover, aberrant expression of N-cadherin was
significantly correlated with pattern of invasion,
histological differentiation and stage grouping in
HNSCC. It has been shown previously that aberrant
expression of N-cadherin in cancer cells can contribute
to invasiveness and metastasis by making the cells more
motile (Hazan et al., 1997; Nieman et al., 1999; Van
Aken et al., 2003). These findings suggest that the
aberrant expression of N-cadherin can be a marker for
prediction of malignant behaviors of HNSCC. Moreover,
it has been shown that ectopic expression of N-cadherin
in epithelial cells induced down-regulation of both E-
cadherin and a scattered fibroblastic phenotype (Islam et
al., 1996). This phenotype is independent of cell-cell
adhesion, depends on the presence of two discrete N-
cadherin protein domains that suppress or modulate
movement, and also depends on the expression of other
proteins interacting with these domains (Islam et al.,
1996; Hazan et al., 1997; Fedor-Chaiken et al., 2003;
Kashima et al., 2003; Kim et al., 2000). Notably, N-
cadherin is able to stimulate tumor cell invasion and
metastasis even in the presence of E-cadherin (Hazan et
al., 1997; Nieman et al., 1999). In this study, high
expression of N-cadherin was observed in 71.4 % of
HNSCC cases with reduced expression of E-cadherin,
and 57.9% of HNSCC cases with preserved expression
of E-cadherin. Moreover, we found that HNSCC cases
with high expression of N-cadherin and preserved
expression of E-cadherin showed a high grade of
invasion pattern and poor differentiation (Fig. 2C, D). N-
cadherin expression tended to be correlated with lymph
node metastasis, but there is no significant difference
(Table 1). Metastasis was not observed in patients at the
resection of tumor, but there is a possibility that a tumor
with high expression of N-cadherin or reduced
expression of E-cadherin may metastasize in the future.
With these results, we suggest that N-cadherin itself may
promote invasion and metastasis of HNSCC cells. As we
found that some HNSCC cell lines with E-cadherin
expression showed N-cadherin expression, we will
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examine whether N-cadherin knockdown affects their
ability to invade and differentiate. N-cadherin interacts
with a number of signal transduction molecules and
contributes to various signaling pathways, such as PDGF
receptor and FGF receptors (Yilmaz and Christofori,
2009). It is interesting to examine the detailed
mechanism of N-cadherin mediated invasion and
metastasis in HNSCC. Overall we suggest that i) N-
cadherin may play an important role in malignant
behaviors of HNSCC, and ii) cadherin switching might
be considered as a discrete critical event in EMT and
metastatic potential of HNSCC. 
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